India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Asthma is on the rise in children, how to prevent it? Asthma is one of the most common chronic problems in children. According to the World Health Organization (WHO), about 300 million people in the world have asthma. The largest number of them are children. Asthma in children is also called childhood asthma. Asthma in adults and asthma in children are different. One of the reasons for the increase in the number of people with asthma is the lack of awareness about its treatment and prevention. To raise awareness about this, ‘Asthma Day’ is celebrated every year on this day. The slogan of World Asthma Day 2025 is ‘Ensure access to inhaler treatment for all’. This slogan emphasizes eliminating unequal access to inhalers, spreading public awareness, improving health systems, and reducing deaths from asthma. Because, there is a lack of information and treatment about asthma in rural and remote areas. In many places, the availability of inhalers is limited and people also have misconce...